November 15th 2024
The target action date for the FDA decision is April 18, 2025, according to Sanofi and Regeneron.
Let’s Get “Real”: Alpha-1 Antitrypsin Deficiency—Case-Based Perspectives on Managing Associated Emphysema
View More
Expert Illustrations & Commentaries™: Picturing the Potential Role of OX40 and OX40L Inhibitors in Atopic Dermatitis
View More
Community Practice Connections™: Navigating a New Era of Food Allergy Management
View More
Allergy Aptitude Test: Round 1
September 1st 2015What allergy-aggravating pollen belongs to genus Ambrosia? What do bananas have in common with ragweed? Is rhinophototherapy the next new treatment for allergic rhinitis? Find answers to these and test your allergy aptitude with a total of 7 questions in round 1 of our quiz.
Allergy, Asthma, and Immunology Meeting Research Update
February 27th 2013Increased exposure to polycyclic aromatic hydrocarbons in air pollution is associated with certain immune system effects and asthma diagnosis, according to research reported the 2013 Annual Meeting of the American Academy of Allergy, Asthma & Immunology.